HomeZVRA • NASDAQ
add
Zevra Therapeutics Inc
Previous close
$8.58
Day range
$8.40 - $8.68
Year range
$6.19 - $13.16
Market cap
475.71M USD
Avg Volume
1.46M
P/E ratio
14.30
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 26.06M | 605.36% |
Operating expense | 20.68M | -27.93% |
Net income | -544.00K | 98.36% |
Net profit margin | -2.09 | 99.77% |
Earnings per share | -0.01 | 98.55% |
EBITDA | 4.54M | 117.65% |
Effective tax rate | 44.32% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 199.51M | 123.22% |
Total assets | 270.12M | 41.02% |
Total liabilities | 136.95M | 12.46% |
Total equity | 133.16M | — |
Shares outstanding | 56.30M | — |
Price to book | 3.62 | — |
Return on assets | 3.94% | — |
Return on capital | 5.52% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -544.00K | 98.36% |
Cash from operations | 4.71M | 125.96% |
Cash from investing | -4.58M | 85.41% |
Cash from financing | 6.53M | -89.92% |
Net change in cash | 6.73M | -54.48% |
Free cash flow | -599.50K | 88.25% |
About
Founded
2006
Website
Employees
59
